Nova Oculus
Blood Flow and Oxygen to the Eyes
One of the Canadian trial's objectives is to confirm our mechanism of action theory: that is, treatment with the Nova Oculus device improves permeability of the blood vessel membranes and cells and allows better oxygen and nutrition delivery to the cells. In other words, pulsed micro-current electrotherapy can re-awaken hibernating cells that impair vision.
If successful, the Canadian and Mexican trials could lead to the commercialization of the Nova Oculus device in those countries for the treatment of dry macular degeneration.